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CD4+ T follicular helper (Tfh) cells are
fundamental for antibody production.
Brenna et al. demonstrate extensive
repertoire overlap between Tfh
populations in human blood and tonsils,
whereas non-Tfh repertoires differ
profoundly. Therefore, analysis of Tfh but
not of total circulating CD4+ T cells can
reflect the specificity of lymphoid tissue
Tfh cells.
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T follicular helper (Tfh) cells are fundamental for B cell
selection and antibody maturation in germinal cen-
ters. Circulating Tfh (cTfh) cells constitute a minor
proportion of the CD4+ T cells in peripheral blood,
but their clonotypic relationship to Tfh populations
resident in lymph nodes and the extent to which
they differ from non-Tfh CD4+ cells have been un-
clear. Using donor-matched blood and tonsil sam-
ples, we investigate T cell receptor (TCR) sharing
between tonsillar Tfh cells and peripheral Tfh and
non-Tfh cell populations. TCR transcript sequencing
reveals considerable clonal overlap between periph-
eral and tonsillar Tfh cell subsets as well as a clear
distinction between Tfh and non-Tfh cells. Further-
more, influenza-specific cTfh cell clones derived
from blood can be found in the repertoire of tonsillar
Tfh cells. Therefore, human blood samples can be
used to gain insight into the specificity of Tfh re-
sponses occurring in lymphoid tissues, provided
that cTfh subsets are studied.
INTRODUCTION
T follicular helper (Tfh) cells are specialized CD4+ T cells pri-
marily found in germinal centers (GCs) of secondary lymphoid
organs (Breitfeld et al., 2000; Kim et al., 2001; Schaerli et al.,
2000). Tfh cells play a critical role in supporting B cell re-
sponses and selection of affinity-matured antibodies (Breitfeld
et al., 2000; Bryant et al., 2007; Ma et al., 2009). They mediate
their effects via receptor-ligand interactions with B cells andC
This is an open access article under the CC BY-Nproduction of cytokines such as interleukin-21 (IL-21), IL-4,
and the B-cell activating factor (BAFF), which induce survival
and proliferation in B cells and support antibody class switch-
ing (Avery et al., 2008; Casamayor-Palleja et al., 1995; Liu
et al., 1989). Expression of the chemokine receptor CXCR5
is fundamental for migration of pre-Tfh cells to the T-B cell
border in lymphoid tissues and maturation of Tfh cells into B
cell follicles and GCs along the follicular CXCL13 gradient (An-
sel et al., 2000; Förster et al., 1996). In addition to CXCR5, Tfh
cells also express PD-1 and ICOS (inducible T-cell costimula-
tor) (Choi et al., 2011; Dorfman et al., 2006; Haynes et al.,
2007; Xu et al., 2013). Some memory CD4+ T cells in second-
ary lymphoid organs express intermediate levels of these
markers, but Tfh cells within the GC (Tfh GC cells) express
high levels of CXCR5 and PD-1; hence, a CXCR5hiPD-1hi
phenotype is commonly used to distinguish Tfh GC cells
(Shi et al., 2018). Differences in expression of these surface
markers reflect the location of CD4+ T cell sub-populations
and their activation, differentiation, and functional status
(Crotty, 2018).
Populations of CD4+ memory T cells in the blood with similar
characteristics as lymphoid Tfh cells are thought to represent
circulating memory Tfh (cTfh) cells (Crotty, 2018; Hale and
Ahmed, 2015). These peripheral cTfh cells express CXCR5,
PD-1, and ICOS but at much lower levels than Tfh GC cells,
although a minute population of circulating PD-1hiCXCR5hi
CD4+ T cells can also be detected (He et al., 2013; Vinuesa
et al., 2016). Although there is some controversy about pheno-
typic definition of cTfh cells, it is accepted that circulating
CXCR5+CD4+ T cells promote immunoglobulin (Ig) class
switching and plasmablast formation in co-culture with naive
or memory B cells (Bentebibel et al., 2013; He et al., 2013; Locci
et al., 2016; Morita et al., 2011). Different subsets of cTfh cells
have been distinguished: Th1-like (CXCR3+CCR6–), Th2-likeell Reports 30, 137–152, January 7, 2020 ª 2019 The Authors. 137
C-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
(CXCR3CCR6–), and Th17-like (CXCR3–CCR6+) cTfh cells,
based on similarities with canonical Th CD4+ cell subpopulations
(Bentebibel et al., 2013; Morita et al., 2011). The diversity of cTfh
cells is also evidenced by the differences in cytokine production
and transcription factor expression observed when cTfh cell
subsets are co-cultured with naive B cells in the presence of
staphylococcal enterotoxin B (SEB). Th1-like subsets produce
interferon g (IFN-g); Th2-like IL-4, IL-5, and IL-13; and Th17-
like IL-17A and IL-22 (Bentebibel et al., 2013; Morita et al., 2011).
The Th2- and Th17-like subsets of cTfh cells provide better B
cell help in vitro than Th1-like cTfh cells (Boswell et al., 2014;
Locci et al., 2013;Morita et al., 2011), and the transcriptional pro-
file of CXCR3– cTfh cells shares a strong similarity with Tfh GC
cells (Locci et al., 2013). In influenza virus infection, the human
CD4+ T cell response is highly Th1-biased, and Th1-like
(CXCR3+) cTfh cells help B cells produce virus-specific anti-
bodies (Bentebibel et al., 2013; Pallikkuth et al., 2012). However,
stimulation of Th1-like Tfh effector cells after infection or vacci-
nation is associatedwith an inferior GC response and suboptimal
antibody production (Bowyer et al., 2018; Cubas et al., 2015;
Obeng-Adjei et al., 2015; Ryg-Cornejo et al., 2016).
Difficulties in sampling secondary lymphoid organs in humans
have hampered direct comparison of lymphoid and peripheral
Tfh cell populations. Furthermore, the ontogeny of memory
cTfh cells and their relationship with effector Tfh GC cells are still
poorly understood. Although the phenotype (Chevalier et al.,
2011; He et al., 2013) and transcriptional profile (Heit et al.,
2017; Locci et al., 2013) of cTfh cell populations have been
compared with Tfh GC cells, the extent of clonal convergence
between these populations has not been fully explored. Pheno-
type and function are plastic features of CD4+ T cells, influenced
by environmental stimuli, so the same cell type can show a
different phenotypic profile in different compartments or under
different cell culture conditions (Sallusto et al., 2018). It has
been unclear whether cTfh cells originate from CXCR5– memory
CD4+ T cells or from lymphoid tissue pre-Tfh or Tfh GC cells or
whether they comprise a distinct lineage. Understanding the
relationship between Tfh and non-Tfh cell populations in the
blood and lymphoid tissues is very important for human studies,
which typically investigate only peripheral blood because of
the practical, ethical, and consensual barriers to accessing
lymphoid tissues.
The T cell receptor (TCR) is a fixed marker of clonotype. In this
study, donor-matched tonsils and peripheral blood were
collected from adult volunteers undergoing tonsillectomy, and
the TCR repertoires of Tfh and non-Tfh cell subsets were
determined. Considerable overlap was found between periph-
eral and tonsillar Tfh cells and a complete disparity between
Tfh cells and CXCR5– memory CD4+ T cells. In addition, memory
Tfh and non-Tfh cells from blood reactive with the hemagglutinin
(HA) protein from influenza virus were studied (Alam and Sant,
2011; Fazilleau et al., 2007; Sant et al., 2018). HA-specific
CD4+ memory T cells were enriched in CXCR3+ cTfh cells, and
HA-specific cTfh cell clones could be found in the tonsillar
CXCR3+ Tfh population, confirming the clonotypic overlap be-
tween peripheral and tonsillar Tfh cell populations in an anti-
gen-specific context. Thus, human blood samples, which are
readily accessible, can be used to gain insight into the specificity138 Cell Reports 30, 137–152, January 7, 2020of Tfh cell responses occurring in GCs, but only when cTfh cell
populations are analyzed.
RESULTS
Identification of Tonsillar and Circulating Tfh
Populations in Donor-Matched Samples
Matched peripheral blood and tonsil samples from adult donors
were studied to compare cTfh and tonsillar Tfh (tTfh) cell popula-
tions. Multi-parameter flow cytometry-based characterization of
CD4+ memory T cell populations in peripheral bloodmononuclear
cells (PBMCs) and mononuclear cells from tonsils (MNC-Ts) was
performed (Figure 1). We refer to all antigen-experienced
(CD4+CD45RA–) cells asmemory cells, although this definition en-
compasses central memory and effector memory/effector T cells,
which we did not distinguish in this study. Expression of the Tfh
markers CXCR5, PD-1, and ICOS and the chemokine receptor
CXCR3 on CD4+CD45RA– memory T cells (identified as shown
in Figure S1A) was evaluated (Figure 1A). A population with high
expression of PD-1 and CXCR5 was observed only in tonsils
and was not present in appreciable numbers in peripheral blood
samples. CXCR3 and ICOS were also differently expressed
among blood and tonsil CD4+ memory T cells (Figure 1B). In ton-
sils, populations with lower expression of CXCR5 and PD-1 had
the highest proportion of CXCR3+ cells, whereas in blood, no sig-
nificant difference was observed between CXCR5+/– and PD-1+/–
subsets. In contrast, ICOS was maximally expressed in tonsil and
blood populations with high expression of CXCR5 and PD-1, and
it decreased as these two markers declined.
Subsets of CD4+ memory T cells were chosen for comparison
based on the phenotypic observations made here and in prior
studies (Boswell et al., 2014; Morita et al., 2011; Figure 1C).
Within the CD4+CD45RA– population, cTfh CXCR3+ and cTfh
CXCR3– subsets of CXCR5+PD-1+ cells and cNon-Tfh cells
(CXCR5–) were identified in peripheral blood. In tonsils, tTfh GC
cells were identified as PD-1hiCXCR5hi, in contrast to the
intermediate level PD-1intCXCR5int population, in which tTfh
CXCR3+ and tTfh CXCR3– cells were characterized, and tNon-
Tfh (CXCR5–PD-1–) cells were also studied. Gates were set
based on the expression of PD-1, CXCR5, and CXCR3 in
CD4+CD45RA+ naive-enriched T cells (Figure S1B). Because
PD-1 is often expressed by exhausted peripheral T cells and in
Th17 CD4+ cells (Aschenbrenner et al., 2018; Day et al., 2006),
we did not include this marker to gate on cNon-Tfh cells from
blood to ensure that we were examining the entire non-Tfh mem-
ory population. The percentage of each population within
CD4+CD45RA– T cells was evaluated in samples collected
from 12 donors (Figure 1D). The Tfh GC subset was not found
in appreciable numbers in peripheral blood, and Tfh subsets
were less frequent in peripheral blood than in tonsils, whereas
non-Tfh cells were more abundant.
To define the functionality of phenotypically distinct Tfh cell
subsets, cytokine production from each subset was evaluated
ex vivo after phorbol 12-myristate 13-acetate (PMA) and ionomy-
cin stimulation, by flow cytometry. Data from 10 donors showed
that Tfh GC cells were the major producers of IL-21 (Figure 1E)
and IL-4 (Figure 1F), both crucial cytokines for Tfh cell differenti-




Figure 1. Identification of Tonsillar and
Circulating Tfh Populations in Donor-
Matched Samples
Matched PBMC and MNC-T from adult donors
were stained ex vivo.
(A) Dot plot illustrating the expression of CXCR5,
PD-1, CXCR3, and ICOS within the total
CD4+CD45RA– cells in a representative matched
blood and tonsil sample pair.
(B) Heatmaps showing the mean percentage of
CXCR3+ and ICOS+ cells within populations ex-
pressing different combinations of CXCR5 and
PD-1 in 12 donors. The white crossed boxes
indicate the near-absence of the PD-1hiCXCR5hi
population in peripheral blood.
(C) Dot plot illustrating the gating strategy used to
define populations of circulating CXCR5+PD-1+
Tfh (cTfh CXCR3+, cTfh CXCR3–) and CXCR5–
non-Tfh memory cells (cNon-Tfh) and tonsillar
CXCR5hiPD-1hi GC Tfh (tTfh GC), CXCR5intPD-1int
(tTfh CXCR3+, tTfh CXCR3–) Tfh and CXCR5–PD-
1– non-Tfh memory cells (tNon-Tfh) within the total
CD4+CD45RA– T cell pool in one representative
donor.
(D) The percentage of each Tfh/non-Tfh subset
within the CD4+CD45RA– memory T cell popula-
tion in blood and tonsils from the 12 donors.
(E–G) Production of IL-21 (E), IL-4 (F), and IFN-g (G)
after PMA and ionomycin stimulation by Tfh and
non-Tfh populations in 10 donors. Non-analogous
subsets were compared within tonsil and periph-
eral blood using the Kruskal-Wallis test. *p < 0.05,
**p < 0.01, ***p < 0.001, ****p < 0.0001. Boxes show
means and quartiles, and whiskers show minima
and maxima.
See also Figure S1.2009; Yusuf et al., 2010). Production of IL-21 was lower in the
other Tfh cell subsets and minimal in non-Tfh cells (Figure 1E).
No significant differences in IL-4 production were observed be-
tween Tfh CXCR3+, Tfh CXCR3–, and non-Tfh cells from both
tonsils and blood (Figure 1F). In line with the low expression of
CXCR3 in Tfh GC cells, this population also exhibited minimal
production of IFN-g (Figure 1G), consistent with published data
(Ma et al., 2009; Ploquin et al., 2011). In contrast, the major pro-
ducers of IFN-g were Tfh CXCR3+ subsets from both tissues
along with peripheral non-Tfh cells, which include canonical
Th1 phenotype cells known to be the highest producers of
anti-viral cytokines within CD4+ cell subsets (Djuretic et al.,
2007; Morita et al., 2011). Examples of cytokine staining for
each cell subset are illustrated in Figures S1C–S1F.
Clonotypic Overlap between Peripheral and Tonsillar
Tfh Cell Populations
To gain insight into the relationship between cTfh and tTfh pop-
ulations, a TCR repertoire analysis was performed. The TCR clo-
notype sequence identifies clonal populations of T cells in
different tissues. To compare the TCR repertoire of CD4+ mem-
ory T cell populations, thawed PBMCs and MNC-Ts from 4
matched donors were stained, and tTfh GC, tTfh CXCR3+, tTfh
CXCR3–, and tNon-Tfh cells from tonsils and cTfh CXCR3+,cTfh CXCR3–, and cNon-Tfh cells from blood were separated
by fluorescence-activated cell sorting (FACS) (8,000–123,000
cells per subset). RNA was extracted, and 50 (RACE) unique
molecular identifiers (UMI)-controlled sequencing of the CDR3
region of the TCR Vb chain repertoire was performed. Because
fewer TCRs were sequenced from lower-frequency cell subsets,
the frequency of each clonotype within its parent population was
normalized, and subsequent analysis was performed on the
most frequent 2,000 clonotypes (top2000) in each sample. This
approach enabled insight to be gained into repertoire sharing be-
tween the most abundant clones in each of the analyzed
populations.
The network analysis in Figure 2 illustrates the clonotypes
shared between each population of blood CD4+ T cells (cTfh
CXCR3– [Figure 2A], cTfh CXCR3+ [Figure 2C], and cNon-
Tfh [Figure 2E]) and the different populations of tonsil (tTfh
GC, tTfh CXCR3+, tTfh CXCR3–, and tNon-Tfh) cells without
showing the connections between the tonsillar populations.
The cTfh CXCR3– population showed the greatest clonotype
sharing with tTfh GC; a total of 6.45% of clonotypes were found
to be shared between these populations overall. This contrasts
with findings from a recent study where no clonal overlap was
observed between tTfh GC and the blood cTfh populations







Figure 2. Clonotypic Overlap between Pe-
ripheral and Tonsillar Tfh Cell Populations
The top2000 TCR CDR3b nucleotide sequences in
each population were analyzed using Cytoscape
networking.
(A, C, and E) As an example, illustrated is clono-
type sharing between peripheral blood cTfh
CXCR3– (A), cTfh CXCR3+ (C), and cNon-Tfh (E)
and 4 tonsillar populations: tTfh CXCR3+ in yellow,
tTfh CXCR3– in blue, tTfh GC in red, and tNon-Tfh
in gray in one representative donor (donor 1). Each
square represents a different clonotype; the size of
the square is proportional to the clonotype’s
normalized frequency within the parent population
(for shared clonotypes, the highest normalized
frequency is shown). The number of clonotypes
shared between different populations is shown in
bold, and the respective percentage is indicated
below.
(B, D, and F) To compare the overlap between
blood cTfh CXCR3– (B), cTfh CXCR3+ (D), and
cNon-Tfh (F) subsets and tonsillar populations, the
percentage of the top2000 most frequent clono-
types shared between populations was calculated
in each of the 4 donors (mean ± SEM). Non-
parametric Kruskal-Wallis and Dunn’s multiple
comparison tests: *p < 0.05, **p < 0.01, ***p <
0.001, ****p < 0.0001.
(G) A heatmap depicting the average number of
clonotypes shared.recent report indicating that thoracic duct T cells with a
CXCR5high and PD-1high phenotype show TCR sharing with
cTfh (Vella et al., 2019). A total of 3.25% of clonotypes were
uniquely shared between cTfh CXCR3– and tTfh GC, whereas
others were also co-shared with the tTfh CXCR3– subset, with
which cTfh CXCR3– also showed clonotype sharing; 2.05% of
clonotypes were shared between all 3 of these populations,
whereas a further 2.15% of clonotypes were uniquely shared
between the cTfh CXCR3– and tTfh CXCR3– subsets (Fig-
ure 2A). In contrast, cTfh CXCR3+ and cNon-Tfh populations
each showed extensive repertoire overlap only with the tonsil
CD4+ population to which they were phenotypically most140 Cell Reports 30, 137–152, January 7, 2020closely related; 12.8% of clonotypes
were uniquely shared between the cTfh
CXCR3+ and tTfh CXCR3+ populations
(Figure 2C), whereas cNon-Tfh cells
uniquely shared 19.2% with tNon-Tfh
cells (Figure 2E). The data shown in
Figures 2A, 2C, and 2E are from donor
1, who underwent tonsillectomy for
sleep apnea, ruling out T cell clonal
distortions driven by repeated tonsil
infections. However, the results ob-
tained with the other donors were
similar, and analysis of the percentage
of clonotypes shared between popula-
tions in each of the 4 donors (shown
in Figures 2B, 2D, and 2F) confirms
the overlap between cTfh CXCR3– andboth tTfh GC and tTfh CXCR3– populations (Figure 2B) and
the extensive clonotype sharing of cTfh CXCR3+ with tTfh
CXCR3+ cells (Figure 2D) and of cNon-Tfh with tNon-Tfh cells
(Figure 2F). The heatmap (Figure 2G) displays the number of
clonotypes shared between populations for all 4 donors.
For a deeper TCR repertoire comparison, it was important to
also consider the size of each clonotype (weighted analysis) to
gauge the repertoire overlap in terms of cell numbers. For each
tonsil and blood comparison, the normalized F2 metric of
VDJtools (Shugay et al., 2013) was calculated. The F2 is the
sum of the geometric means between the frequencies of shared




Figure 3. Size Similarities in Clonotypes Shared between cTfh and tTfh
(A–C) Overlap between TCR CDR3b nucleotide sequences of the top2000 most frequent clonotypes of blood cTfh CXCR3– (A), cTfh CXCR3+ (B), and cNon-Tfh
(C) populations with each tonsil population, as represented by the normalized F2 metric (mean ± SEM). Non-parametric Kruskal-Wallis and Dunn’s multiple
comparison test: *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001.
(D–H) Linear regression analysis of the correlation between the within-population frequency of the shared clonotypes in the two parent populations where
clonotype sharing between populationswas observed: cTfh CXCR3–with tTfh GC (D), tTfh CXCR3–with cTfh CXCR3– (E), cTfh CXCR3–with tTfh CXCR3+ (F), cTfh
CXCR3+ with tTfh CXCR3+ (G), and cNon-Tfh with tNon-Tfh (H). Each graph illustrates a representative donor, and the tables show the number of shared clo-
notypes, the square of the Pearson correlation coefficient (R2), the slope value for each donor, and the p value of the significance of the difference in the slope from
zero (ns, not significant).higher the number of T cells bearing the shared TCR variants
(Izraelson et al., 2018). This analysis confirmed the repertoire
similarity of cTfh CXCR3– with tTfh GC and tTfh CXCR3– popula-tions and identified a connection between cTfh CXCR3– and tTfh
CXCR3+ cells (Figure 3A). Likewise, the F2 metric also validated










Figure 4. Repertoire Diversity Correlates with the Degree of Clonotypic Overlap from the In Silico Resampling Analysis
(A and B) Chao1 index (A) and normalized Shannon-Wiener index (B) of the top2000 frequencies for each population of cells analyzed in blood and tonsils from the
4 donors (mean ± SEM). Clonotypes of each subset were resampled using the bootstrap method.
(C and D) The percentage of the top2000 shared clonotypes and the normalized F2 metric (mean ± SEM) of the overlap between the two replicates of blood (C)
cTfh CXCR3+, cTfh CXCR3–, and cNon-Tfh as well as tonsil (D) tTfh GC, tTfh CXCR3+, tTfh CXCR3–, and tNon-Tfh populations is shown for all 4 donors
(mean ± SEM). Non-parametric Kruskal-Wallis and Dunn’s multiple comparison test: *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001.
(legend continued on next page)
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and the extensive overlap of cNon-Tfh with tNon-Tfh cells and
identified weaker connections with tTfh populations (Figure 3C).
To better visualize the similarity between these two compart-
ments, where clonotype sharing was observed, the frequencies
of each shared clonotype were analyzed by linear regression.
Although there was consistent overlap between cTfh CXCR3–
and tTfh GC cells (Figure 3D), comparison of the relative sizes
of clonotypes shared by the two different compartments was
significant in only 2 of the 4 donors, with a low Pearson correla-
tion coefficient (R2; 0.08 and 0.14). In all cases, the slope of the
correlation was less than 1, indicating that, in tonsils, most of
the clonotypes are more expanded than in the blood. A similar
scenario was observed for cTfh CXCR3– versus tTfh CXCR3–
subsets (Figure 3E) and cTfh CXCR3– versus tTfh CXCR3+ pop-
ulations (Figure 3F). The correspondence between cTfh CXCR3+
and tTfh CXCR3+ populations remained the strongest; the sizes
of the clonotypes shared between these populations were also
very similar, significant (p < 0.0001) in 3 of the 4 donors (Fig-
ure 3G). For the cNon-Tfh and tNon-Tfh comparison, despite
the high number of clonotypes shared (124–386), the size of
the clonotypes was very different between blood and tonsils,
making the linear correlation significant in only 1 of the 4 donors
(Figure 3H).
Repertoire Diversity Correlates with the Degree of
Clonotypic Overlap from the In Silico Resampling
Analysis
To compare the repertoire diversity of each population, the non-
parametric Chao1 index (Figure 4A) was calculated to estimate
the richness of the number of unobserved elements in the set
considered (Colwell et al., 2012; Eren et al., 2012). The normalized
Shannon-Wiener indexwasalsocalculated tomeasure theentropy
of each TCR sequence population (Figure 4B) based on the uncer-
tainty of predicting the next sequence in a string. The two parame-
ters describe the repertoire diversity from different perspectives;
Chao1 is based on relative distributions of low-frequency clono-
types, whereas Shannon-Wiener takes into account large clonal
expansions (Izraelson et al., 2018).Notably, an increaseofdiversity
was observed in blood from cTfh CXCR3+ to cTfh CXCR3– and
cNon-Tfh cells; likewise, in tonsils, tTfh GC cells were less diverse
than tNon-Tfh subsets, which showed the highest value of both
Chao1 and normalized Shannon-Wiener index values.
To improve our understanding of the magnitude of the overlap
observed between CD4+ T cell subsets in blood and tonsils,
which was based on analysis of a limited number of cells from
each population, an in silico replication using the bootstrap
methodwas applied to re-sample the clonotypes in each subset.
When re-sampling the same subset twice, populations from the
blood (Figures 4C and S2A) showed, on average, an overlap be-
tween sampling 1 and sampling 2 of 50%, with cTfh CXCR3+
cells slightly higher (60%–70%). In tonsil populations (Figures
4D and S2A), the highest reproducibility was reported for tTfh(E and F) Unweighted (E) andweighted (F) analysis of the replicate overlap at increa
CXCR3+ from donor 1).
(G) The graphs show the linear regression correlation between the repertoire ov
metric, with both diversity indexes (Chao1 and normalized Shannon-Wiener) in a
See also Figure S2.GC cells, with decreasing levels of overlap observed for tTfh
CXCR3+ and tTfh CXCR3– populations and the lowest with
tNon-Tfh cells. A similar trend was reported from the weighted
analysis represented by the F2 metric analysis.
When increasing the number of clonotypes considered, the pre-
diction did not reach complete overlap but, rather, a plateau of
60% of unweighted (Figure 4E) and 0.8 weighted (Figure 4F) anal-
ysis, respectively. As expected, the degree of overlap was
inversely related to population diversity (Figure 4G) and was
more pronounced for tonsils compared with blood, confirming
that, when a population is less diverse, the degree of overlap on
in silico resampling is higher. The overlap of the same population
was also assessed experimentally in non-Tfh (Figure S2B) and Tfh
cells (Figure S2C) from 3 additional donors and was found to be
less than 30% for non-Tfh and less than 52% for Tfh subsets.
These results show that, even when re-sampling exactly the
same set of sequences or sequencing two vials of the same
sorted population, the repertoire overlap is never complete
(100% and F2 = 1), and it changes depending on the diversity
of the subset considered and the size of the sample (Shugay
et al., 2013). This implies that the degree of overlap observed
experimentally is an underestimate, reflecting the relatively small
sample size and reinforcing the conclusion that there is substan-
tial repertoire overlap between blood and tonsil Tfh populations.
Tfh Cell Subsets Are Clonotypically Distinct from Non-
Tfh Cells
Whether Tfh cells make up a distinct population of CD4+ T cells
with a unique program of differentiation or are a subset of the
memory CD4+ T cell compartment in a transient activation state
is still debated (Baumjohann et al., 2013; Crotty, 2014; Herati
et al., 2017; Vinuesa et al., 2005; Weber et al., 2015).
A cytoscape networking analysis revealed only a very low level
of TCR Vb repertoire overlap between cTfh CXCR3+, cTfh
CXCR3–, and cNon-Tfh populations in the blood compartment
(Figure 5A). This was true for both comparisons of cTfh CXCR3+
versus cTfh CXCR3– (0.8%) and cTfh subsets versus cNon-Tfh
(0.3%–1%) populations. In addition, very few clonotypes were
shared between all 3 populations (0.2%). These results were
consistent across all 4 donors analyzed (Figure S3). Similarly,
tTfh cells (either CXCR3+, CXCR3–, or GC) were also notably
distinct from the tNon-Tfh population (Figure 5B), with very little
repertoire overlap (0.1%–0.3%). In contrast, the 3 tTfh populations
showed considerable overlap with each other: tTfh CXCR3+ with
tTfh CXCR3– and Tfh GC (0.8%–3.1%), tTfh CXCR3+ with tTfh
GC (3.6%–7.4%), tTfh CXCR3– with tTfh GC (4%–14.9%), and
tTfhCXCR3+with tTfhCXCR3– (2.7%–6.3%) (Figure 5C). Although
the extent of the repertoire overlap between the tTfh populations
was variable in different donors, clonotype sharing between the
3 tTfh cell populationswas observed in all 4 donors, especially be-
tween the tTfh CXCR3– and tTfh GC subsets. A normalized F2
metric analysis confirmed the overlap between tTfh CXCR3– andsing numbers of clonotypes considered from a representative population (cTfh
erlap, expressed either as percentage of shared clonotypes or normalized F2
ll blood and tonsil populations from the 4 donors analyzed.





Figure 5. Tfh Cell Subsets Are Clonotypi-
cally Distinct from Non-Tfh Cells
The top2000 TCR Vb CDR3 nucleotide sequences
of each population were analyzed by Cytoscape
networking.
(A and B) Examples of (A) clonotype sharing
between peripheral blood cTfh CXCR3+ (yellow),
cTfh CXCR3– (blue), and cNon-Tfh (gray) pop-
ulations and (B) clonotype sharing between
tonsillar populations tTfh CXCR3+ (yellow), tTfh
CXCR3– (blue), tTfh GC (red), and tNon-Tfh (gray)
populations in one representative donor (donor 1).
Results are expressed as in Figure 2.
(C) The percentage of the top2000 total shared
clonotypes in addition to the uniquely shared
clonotypes between tonsil populations was
calculated in each of the 4 donors (mean ± SEM).
(D) The normalized F2 metric of the top2000 fre-
quencies was also calculated for the overlap be-
tween tTfh CXCR3+ and tTfh CXCR3– subsets and
each of the other populations analyzed in the 4
donors (mean ± SEM). Non-parametric Kruskal-
Wallis and Dunn’s multiple comparison test: *p <
0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001.
(E) The table shows the number of shared clono-
types, the square of R2 in their size within pop-
ulations, the slope value, and the p value of the
difference in the slope from zero.
See also Figure S3.tTfh GC subsets and the repertoire distance between all tTfh pop-
ulations and tNon-Tfh (Figure 5D). Despite the numerous clono-
types shared between tTfh CXCR3+ and tTfh CXCR3– (70–172),
tTfh CXCR3+ and tTfh GC (89–214), and tTfh CXCR3– and tTfh
GC (96–360), the relative immunodominance of the shared clono-
types differed substantially; the correlationswereR2 < 0.36 and, in
the majority of cases, not significant (Figure 5E).
Influenza Virus HA-Specific Clones Are Predominantly
Found in cTfh CXCR3+ and cNon-Tfh Populations
To compare the repertoire of antigen-specific Tfh and non-Tfh
cells in peripheral blood and their representation in tonsil popu-144 Cell Reports 30, 137–152, January 7, 2020lations, responses to the HA protein H3
from influenza virus A/Wisconsin/67/
2005 were studied (Alam and Sant,
2011; Fazilleau et al., 2007; Sant et al.,
2018). To assess the relative abundance
of memory CD4+ T cells reactive with
HA protein, the T cell library method (Gei-
ger et al., 2009) was used to determine
the precursor frequency of HA-reactive
cells in isolated memory CD4+ T cell pop-
ulations and to characterize the cTfh and
cNon-Tfh CD4+ memory repertoire in 3
healthy donors, samples from whom
were obtained from the National Health
Service (NHS) Blood Transfusion Service
(Figure 6A). All 3 donors showed enrich-
ment of HA-specific T cells in the cTfh
CXCR3+ and cNon-Tfh populations. Fewresponding HA-specific cTfh CXCR3– cells were found, and
they were only detected in donor A. The precursor frequency
of antigen-specific cells per million was calculated within each
subset (Figure 6B). Donors A and B showed the highest HA-spe-
cific precursor frequency in both cTfh CXCR3+ and cNon-Tfh
populations (530–550 and 280–150 antigen-specific cells/
million). The differences observed in the 3 donors analyzed likely
reflects the diverse prior antigenic exposure of each individual.
Having shown that HA-specific cTfh cells were present in pe-
ripheral blood, the antigen-specific cTfh repertoires of 4 further
donors, from whom tonsil samples were available in addition to




Figure 6. Influenza Virus HA-Specific Clones Are Predominantly Found in cTfh CXCR3+ and cNon-Tfh Populations
(A) T cell libraries generated from Tfh and non-Tfh subsets sorted from three healthy blood donors from the National Health Service (NHS) Blood Transfusion
Service were tested against the influenza H3/Wisconsin HA protein. The proliferation of each individual cell line (increase in counts above background, delta cpm)
is shown (mean ±SEM). The red dotted line represents the cutoff used for identification of a positive response (defined as >3000 cpm,with a stimulation index >5).
(B) Calculated precursor frequency of HA-specific cells per 106 cells in each subset (mean ± SEM).
(C) Bar graph showing the number of influenza H1/California HA-specific T cell clones generated from each cell subset in the 4 further donors fromwhommatched
tonsil samples were available. Non-parametric Kruskal-Wallis and Dunn’s multiple comparison test: *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001.
(D) Epitopes recognized by HA-specific cTfh CXCR3+, cTfh CXCR3–, and cNon-Tfh clones were mapped, and the frequency of clones recognizing each peptide,
normalized to the total frequency of HA-specific clones in all donors (D1, D2, D3, and D4), is plotted in the heatmap. The solid arrows highlight the peptides
recognized by 3 subsets and the dashed arrows the peptides recognized by 3 donors.
See also Figure S4.with the entire repertoire of T cells in tonsillar cell subsets from
the same individual. To confirm influenza virus exposure, plasma
samples from the 4 donors were screened for the presence ofHA-specific antibodies, evaluating immunoglobulin G (IgG) reac-
tivity with HA protein from influenza virus strain A/California/07/




Figure 7. HA-Specific cTfh and cNon-Tfh Clones Do Not Overlap, and HA-Specific cTfh CXCR3+ T Cell Clonotypes Can Be Detected in the
tTfh CXCR3+ Subset
(A) TCR CDR3⍺ and CDR3b sequencing was performed on clones specific for the same HA H1/California peptide that had been generated from either the cTfh
CXCR3+, cTfh CXCR3–, or cNon-Tfh subset in 3 donors. For each clone, the peptide specificity, the CDR3⍺ and CDR3b amino acid (AA) sequences, and TRAV/
TRAJ and TRBV/TRBJ gene usage are shown. Clones are grouped based on the peptide recognized.
(legend continued on next page)
146 Cell Reports 30, 137–152, January 7, 2020
H3, and B) influenza vaccine 2017 (TIV) (Figure S4B) by ELISA.
IgG antibodies reactive with both HA protein and TIV were de-
tected in all 4 donors. Tfh cell clones specific for HA protein
(H1) were then generated from peripheral blood cTfh CXCR3+,
cTfh CXCR3–, and cNon-Tfh populations of each donor. As
shown in Figure 6C, the highest numbers of HA-specific clones
were derived from either cTfh CXCR3+ or cNon-Tfh populations.
These were the subsets in which antigen-specific cloning effi-
ciency was greatest (Figure S4D). Based on the percentage of
activated ICOS+CD25+ cells after 7 days of stimulation (Fig-
ure S4C) and the proportion of the clones generated from the
activated populations that were subsequently confirmed to be
HA-reactive by proliferation, it was possible to gain estimates
of the number of HA-specific cells within each subset (Fig-
ure S4E) or within the CD4+ memory compartment (Figure S4F).
The data confirmed that HA-specific T cells were enriched in the
cTfh CXCR3+ and cNon-Tfh populations, whereas, as expected,
only a few HA-specific cells were found in the cTfh CXCR3–
compartment (Bentebibel et al., 2013; Pallikkuth et al., 2012).
The epitopes recognized by HA-specific T cell clones were
then mapped using a matrix of overlapping peptides from HA/
California (H1). The data from cTfh CXCR3+ and cNon-Tfh
clones highlighted the breadth of HA epitopes recognized in
each donor and suggested a difference in the pattern of epi-
topes recognized by cTfh and cNon-Tfh subsets because
only a few peptides per donor were recognized by all three
types of cells (Figure 6D, solid arrows). Epitopes recognized
by at least 3 donors are highlighted in Figure 6D with dashed ar-
rows; peptide 433–450 was the most universally targeted, be-
ing recognized by cTfh CXCR3+ clones from donors 2, 3, and
4 and by cNon-Tfh clones from donors 1, 2, and 3. The number
of cTfh CXCR3– clones was low, and none of the clones recog-
nized epitopes targeted in at least 3 donors, including peptides
433–450 and 441–458.
HA-Specific cTfh CXCR3+ T Cell Clonotypes Can Be
Detected in the tTfh CXCR3+ Subset
To determine whether clones with the same peptide specificity
also express the same TCR, the CDR3a and CDR3b gene tran-
scripts of a subset of HA-specific clones from donors 1, 2, and
3 were sequenced (Figure 7A). These data showed that, when
cTfh CXCR3+, cTfh CXCR3–, and cNon-Tfh cell clones were spe-
cific for the same peptide (for example, peptide 225–242 for do-
nors 1 and 2 and peptide 177–194 for donor 3), they did not share
the same CDR3 region and were therefore clonotypically
distinct. In some cases, even when 2 clones were specific for
the same peptide and belonged to two different lineages, they
used TCRa or TCRb chains from the same family. For instance,
in donor 2, clones 49 (cTfh CXCR3+), 1 (cTfh CXCR3–), and 42
(cNon-Tfh) specific for peptide 225–242 exhibited different
CDR3a sequences, but all three TCRa chains belonged to the(B and C) The TCRCDR3⍺ andCDR3b region sequences of 75 HA-specific clones
Vb repertoires of tonsil and blood Tfh and non-Tfh populations from the same su
donor 2. The frequency distributions of each of the individual clonotypes detected
are shown, with yellow circles indicating the sequences that matched those of th
same donor.
See also Figure S5.same TRAV23/DV6 family. Also, in donor 3, clones 1 (cTfh
CXCR3+) and 1 (cTfh- CXCR3–) specific for peptide 177–194,
which again had different CDR3a sequences, possessed TCRb
chains belonging to the same family (TRBV2). Additional se-
quences from donor 1 are shown in Figure S5A.
We next investigated whether the TCRa or TCRb chain se-
quences identified in HA-specific T cell clones were detectable
in the overall repertoire of CD4+ T cell subsets from both tonsils
and peripheral blood, which had been evaluated by non-paired
sequencing of ab TCRs. Because both the TCRa and TCRb
chain of each HA-specific T cell clone were available, it was
possible to determine the presence or absence of each clono-
type on the basis of detection of both chains in the subsets
analyzed. Although only 75 HA-specific clones were sequenced,
3 cTfh CXCR3+ clones from donor 2 were found in the tTfh
CXCR3+ repertoire from the same donor (Figure 7B), and two
clones, also from donor 2, were detected in the cTfh CXCR3+
subset (Figure 7C). The tables show the frequency of the clono-
type of interest observed in tonsils (Figure S5B) and in blood (Fig-
ure S5C) for both TCR chains. The presence of HA-specific Tfh
clones initially derived from PBMCs in the tTfh CXCR3+ reper-
toire of the same donor confirmed the direct relationship be-
tween antigen-specific circulating and tTfh cells.
DISCUSSION
This work analyses the clonotypic overlap of Tfh cell subsets
from peripheral blood and tonsillar cell populations. Repertoire
sharing was selectively detected between blood and tonsillar
populations with similar phenotypic characteristics, defined as
cTfh CXCR3+ and tTfh CXCR3+, cTfh CXCR3– and tTfh GC/
tTfh CXCR3–, and cNon-Tfh and tNon-Tfh subsets. These results
suggest that, in a steady-state condition, the clonal composition
of the CXCR5+PD-1+ circulating cTfh population reflects that of
tonsil-resident tTfh cells. The TCR repertoire analysis also pro-
vided evidence of a clear distinction between Tfh and non-Tfh
cell populations. These observations were confirmed by a paral-
lel analysis of antigen-specific T cell clones recognizing HA from
influenza virus. Therefore, separation of Tfh cells from the total
memory CD4+ T cell pool is necessary to investigate the speci-
ficity of the follicular T cell response.
In line with previous observations, Tfh GC cells (CXCR5hiPD-
1hi) were the major sources of IL-21 and IL-4 and were only pre-
sent in tonsils (Dan et al., 2019; He et al., 2013; Heit et al., 2017;
Locci et al., 2013). The presence of effector Tfh GC cells in tonsils
suggested a probable ongoing immune response in this tissue
(Baumjohann et al., 2013; Hansen et al., 2017; Havenar-Daugh-
ton et al., 2016), which was likely driven by residual antigen from
prior infections because antigen can persist for months or years
on follicular dendritic cells in draining lymph nodes (Tew and
Mandel, 1979; Tew et al., 1984), We showed that Tfh GC cellsgenerated from the blood populations were determined, and the ex vivo V⍺ and
bject were searched for matching sequences. Matches were detected only in
in the tonsil tTfh CXCR3+ (B) and peripheral blood cTfh CXCR3+ (C) repertoires
e HA-specific cTfh CXCR3+ clones generated from the peripheral blood of the
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are enriched in CXCR3– cells and produced little IFN-g (Ma et al.,
2009; Ploquin et al., 2011). The lack of CXCR3 expression by Tfh
GC cells is consistent with their specific effector function inside
the GC, where they do not need to directly face inflammation but
actively participate in formation of neutralizing antibodies (Dju-
retic et al., 2007; He et al., 2013). Phenotypic features highlighted
similarities, in particular between tTfh CXCR3+ and cTfh CXCR3+
subsets, but also heterogeneity between blood and tonsil popu-
lations (Chevalier et al., 2011; He et al., 2013). These differences
may be driven by stimuli present in the respective local environ-
ments (Wong et al., 2016) and reflect selective recruitment,
retention, or differentiation of populations at particular sites (Du-
rand et al., 2019).
To better determine the relationship between circulating and
tTfh cell populations, we explored TCR repertoires, given that a
cell’s TCR does not change with cellular location or differentia-
tion. The vast TCR diversity within each individual (estimated at
108) and the number of cells sequenced per sample (103–105) al-
ways constrains TCR repertoire studies and poses caveats
requiring the use of technical or in silico replicates to confirm
the primary observations. However, TCR deep sequencing high-
lighted correlations between tonsil and blood Tfh and non-Tfh
populations. Although RNA-based TCR sequencing provides
relatively good repertoire coverage, it is not possible to calculate
the absolute frequency of each clonotype with the analyzed pop-
ulations (Heather et al., 2018; Rosati et al., 2017). However, we
combined both weighted (the F2 metric) and unweighted (per-
centage of shared clonotypes) analyses and observed similar
trends, validating the repertoire overlap observed between
populations.
Effector Tfh GC cells from tonsils and tTfh CXCR3– cells
showed a moderate repertoire overlap with cTfh CXCR3– cells
from peripheral blood. Although a Tfh GC/cTfh CXCR3– relation-
ship between tonsils and blood has been demonstrated previ-
ously in terms of gene expression (Locci et al., 2013), our anal-
ysis of donor-matched tissues directly demonstrates that the
same Tfh clones are present in both tonsils and the blood
CXCR5+PD-1+ cTfh compartment. The relatively modest overlap
might be explained by the specific and localized role of Tfh GC
cells during their effector phase in the GC (Groom and Luster,
2011). Consistent with this, we observed that shared clonotypes
are more expanded in tonsils than in blood, suggesting selective
retention of a locally expanded Tfh population. The clonotype
sharing between tTfh GC and tTfh CXCR3– cells may reflect
the fact that both are enriched for cells recognizing locally
presented antigens, with Tfh GC potentially originating from or
sharing common precursors with Tfh CXCR3– (Crotty, 2018;
Locci et al., 2013). In contrast, the cTfh CXCR3– population prob-
ably has a much more promiscuous origin because it is likely to
contain antigen-experienced Tfh cells that have exited from
lymphoid tissues before or after becoming effector Tfh GC cells
during both the ongoing and prior immune responses. It is also
possible that cTfh cells are recruited from the periphery in
response to local chronic infection in the tonsils.
This study does not address the differentiation and generation
of Tfh CXCR3+ cells, but the convergence in clonotypic repertoire
observed between peripheral blood and tonsils was striking. This
suggests high mobility of these types of cells from secondary148 Cell Reports 30, 137–152, January 7, 2020lymphoid organs to the peripheral circulation or vice versa. The
minor but consistent repertoire sharing between Tfh CXCR3+
and Tfh CXCR3– cells in tonsils may result from tTfh cell differen-
tiation from one phenotype to the other or plasticity among
CXCR3+ and CXCR3– phenotypes, observed previously in canon-
ical T helper subsets (Becattini et al., 2014; Hegazy et al., 2010).
The repertoire sharing observed between non-Tfh cells in ton-
sils and blood confirms communication between the two tissues
and suggests that, after priming, CD4+ T cells from secondary
lymphoid organs may exit into the peripheral circulation to pur-
sue their effector function but also that circulating non-Tfh cells
may be recruited to the tonsils to react to ongoing chronic infec-
tion. Despite the consistent overlap, the weighted analysis
showed that the size of clonotypes differed between the two
compartments, indicating that these populations have a different
clonotypic distribution, which probably reflects differing reten-
tion and expansion in different locations.
To better understand themagnitude of the observed repertoire
overlaps, it is necessary to consider the size of the analyzed
samples (103–105 cells) in comparison with the entire CD4+
T cell repertoire (108 cells) in the human body, with the caveat
of considering a fixed number of the most abundant clones in
each subset. Importantly, it was observed that, when re-sam-
pling exactly the same set of sequences in silico or by experi-
mentally sequencing cells independently sorted from the same
tissue sample, the repertoire overlap is never complete, and it
decreases with increasing population diversity. These quantita-
tive results suggest that the degree of overlap observed experi-
mentally between separately sampled populations provides an
underestimate of the considerable repertoire overlap between
circulating and tTfh populations.
Extending the analysis to antigen-specific populations, we
showed, using the T cell library technique (Geiger et al., 2009),
that HA-specific CD4+ T cells were enriched in the cTfh CXCR3+
subset and the cNon-Tfh population, which contains the canoni-
cal CD4+ Th1 subsets. The number of HA-specific clones gener-
ated from the cTfh CXCR3+ and cNon-Tfh compartments was
also much higher than that generated from the cTfh CXCR3–
pool. The CD4+CXCR3+ bias in the HA-specific response is in
line with previous reports (Palladino et al., 1991; Pedersen et al.,
2014; Valkenburg et al., 2018; Velu et al., 2016; Yang et al.,
2013; Yoon et al., 2018; Zielinski et al., 2011). Notably, in one of
the 3 donors studied, the TCR sequences of blood-derived HA-
specific cTfh CXCR3+ clones were found in the tTfh CXCR3+
repertoire, supporting a common clonal origin of antigen-specific
Tfh cells in tonsils and the circulation. These results from analysis
of antigen-specific cells provide strong support for the conclu-
sions drawn from TCR deep sequencing: that the repertoires of
cTfh and tTfh cells are very similar to each other but distinct
from non-Tfh populations. Our observation of some repertoire
sharing between Tfh GC and tTfh CXCR3+ populations is consis-
tent with the hypothesis that some of the cells participating in a
GC reaction originate from the tTfh CXCR3+ pool (Crotty, 2018;
He et al., 2013). Whether a few Tfh GC cells, originally primed in
a Th1 environment, are surviving to become memory Tfh
Th1-like (or CXCR3+) cells in the lymphoid organs and later
in the periphery is not clear (Crotty, 2018). Tfh GC cells may
revert, via a tTfh CXCR3– stage, to a tTfh CXCR3+ phenotype
because we observed some modest repertoire overlap between
all three of these tTfh populations as well as repertoire overlap
unique to the tTfh CXCR3– and tTfh CXCR3+ populations. These
observations may apply to other Tfh cells with different pheno-
types, similar to canonical Th cell subsets, but future work
focusing on different pathogens that drive Th2 or Th17 responses
is needed to elucidate this further.
Our TCR repertoire analysis also indicated very little overlap
between antigen-experienced Tfh and non-Tfh cell populations
in blood and tonsil tissues under steady-state conditions. This
may suggest that these memory cells are derived from distinct
clonal lineages, although it does not exclude the possibility that
memory CD4+ T cells, which are known to exhibit plasticity (Be-
cattini et al., 2014; Caza and Landas, 2015; Hegazy et al., 2010;
O’Shea et al., 2010), may alter their phenotype and become Tfh
cells during an acute immune response (Boyden et al., 2012;
Pepper et al., 2011). However, given that only the top2000
most abundant clonotypes in each population were compared,
we cannot preclude that clones that were more highly
expanded in the Tfh compartment were not also present at
low frequency in the non-Tfh compartment and vice versa.
Nonetheless, there were substantial differences in the TCR rep-
ertoires of antigen-experienced Tfh and non-Tfh populations.
Furthermore, when studying influenza virus-specific cells (in
the absence of a current influenza infection), we found that
the peptides recognized by HA-specific CD4+ T cell clones
showed a wide diversity of specificities, and there was a sur-
prisingly small overlap in the peptides recognized by Tfh and
non-Tfh subsets. The distinction between Tfh and non-Tfh sub-
sets in peripheral blood was uniquely confirmed by the combi-
nation of TCR sequencing and peptide specificity testing for
cTfh CXCR3+, cTfh CXCR3–, and cNon-Tfh HA-reactive T cell
clones; the results indicated that these cells were generated
from different naive clones. Future studies should explore the
differences between repertoires of Tfh and non-Tfh cells in
blood and GC over the course of acute responses to infection
or vaccination.
Non-Tfh cells constitute the majority of the CD4+ T cell pop-
ulation in the blood (PD-1+CXCR5+ cTfh cells comprise only
15% of memory and 6% of total blood CD4+ T cells), and, for
many years, measurement of total CD4+ T cell responses in
PBMCs has been used to assess the magnitude of helper
T cell responses in the context of B cell and antibody re-
sponses. Our findings show that evaluation of the overall anti-
gen-specific CD4+ T cell response will not give an accurate pic-
ture of the response in the Tfh compartment. There was very
little clonal overlap between bona fide helper Tfh cells, particu-
larly Tfh GC cells, and CXCR5–CD4+ memory T cells in the
blood or tonsils, and there were marked differences in the
epitope specificity of HA-reactive cTfh and cNon-Tfh cells.
However, there were significant overlaps between the
CXCR5+ Tfh populations in the blood and Tfh cells in lymphoid
tissues. Therefore, to investigate the specificity of true Tfh re-
sponses, it will be necessary to identify circulating Tfh cells
and to study their antigen reactivity. These findings have impor-
tant implications for evaluating the breadth and specificity of
immune responses in clinical trials of vaccines aimed at stimu-
lating protective antibody responses.STAR+METHODS
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EXPERIMENTAL MODEL AND SUBJECT DETAILS
Human studies
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(Table S6). Tonsillectomy was performed in the absence of acute infection. Patients were excluded from the study if they were
affected by immunodeficiency, serious ongoing infection (e.g., hepatitis B, hepatitis C or HIV infection or other infections deemed
by the investigators to impact on the study), lymphoid malignancy, cytogenetic disorders, history of cancer, any pre-existing heart
disease or a blood clotting disorder. The existing LABFLU002 clinical protocol was amended to cover these studies andwas ethically
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donors via the UK National Blood Service.
METHOD DETAILS
Human sample processing
Tonsil nodules from adult donors were collected within 4 h of surgery into RPMI 1640 glutamine [-] medium (Invitrogen) supplemented
with non-essential amino acids (1%, Invitrogen), sodium pyruvate (1%, Invitrogen), glutamine (1%, Invitrogen), pooled AB human
sera (5%,UKNational Blood Service), b-mercaptoethanol (0.1%, Invitrogen) and penicillin/streptomycin (1%, Invitrogen). All samples
were kept on ice during transportation. Tonsillar tissues were cleared from fatty and necrotic areas and cut into sections at a
thickness of 2–3 mm using scalpels and scissors. The sections were then passed through a 70 mm cell strainer and filtered through
a 40 mm cell strainer (Grivel and Margolis, 2009). Manually processed tonsils and peripheral blood samples were diluted 1:2 with
Hank’s Balanced Salt Solution (Sigma-Aldrich) and layered over 20 mL of Histopaque-1077 (Sigma-Aldrich). Mononuclear cells
were isolated via density gradient centrifugation (800 g for 30 min). Flow cytometric analyses of phenotypic markers were performed
directly ex vivo. CD14+ cells were enriched from PBMCs via magnetic separation using CD14 MicroBeads (Miltenyi Biotec).
Phenotypic analysis and intracellular cytokine staining
Mononuclear cells from tonsil and blood samples were washed in Dulbecco’s PBS (Sigma-Aldrich). For phenotypic analyses, cells
were labeled with Live/Dead Fixable Aqua and surface stained with anti-CD4–APC-Cy7, anti-CD45RA–PE-TxRed, anti-CXCR3–PE-
Cy5, anti-CXCR5–AF488, anti-ICOS–BV711, anti-PD-1–BV421 and the dump markers anti-CD8, anti-CD14, anti-CD16, anti-CD19,
anti-CD25 and anti-CD56 (all conjugated to PE-Cy7) for 15 min at 37C (reagent details in Key Resources Table). For cytokine
production, cells were stimulated with phorbol 12-myristate 13-acetate (2 3 107 M, Sigma-Aldrich) and ionomycin (1 mg/mL,
Sigma-Aldrich) for 5 hr at 37C. Brefeldin A was added after 2 hr (10 mg/mL, Sigma-Aldrich). Cells were then surface stained as
described above, fixed/permeabilized with Cytofix/Cytoperm 1X Solution (BD PharMingen), and stained in Permwash 1X Solution
(BD PharMingen) with anti-CD4–APC-Cy7, anti-IFN-g–AF700, anti-IL-4–PE and anti-IL-21–AF647 for 20 min on ice (reagent details
in Key Resources Table). The flow cytometry panel was internally validated using individually stained CompBeads (BD Biosciences).
Stained samples were acquired using an LSR Fortessa (BD Biosciences) and analyzed using FlowJo software v10.3 (Tree Star).
CD4+ T cell library
CD4+ and CD14+ cells were enriched from the PBMCs of 3 healthy donors via magnetic separation using the corresponding
MicroBeads (Miltenyi Biotec). The CD14+ fraction was cryopreserved in liquid nitrogen. CD4+ T cells were stained with Live/Deade2 Cell Reports 30, 137–152.e1–e5, January 7, 2020
Fixable Aqua, anti-CD3–BV605, anti-CD4–APC-Cy7, anti-CD45RA–PE-TxRed, anti-CXCR3–PE-Cy5, anti-CXCR5–AF488, anti-PD-
1–BV421 and the dumpmarkers anti-CD8, anti-CD14, anti-CD16, anti-CD19, anti-CD25 and anti-CD56 (all conjugated to PE-Cy7) for
15 min at 37C (reagent details in Key Resources Table). Circulating live CD3+CD4+CD45RA– cells were sorted into cTfh CXCR3+
(CXCR3+CXCR5+PD-1+), cTfh CXCR3– (CXCR3–CXCR5+PD-1+) and cNon-Tfh (CXCR5–) subsets using a FACSAria III (BD Biosci-
ences). Sorting was performed using a 4-way purity to obtain 3–5x105 cells per subset at a minimum purity of 92%. Sorted CD4+
T cells were seeded at a limiting dilution of 1 3 104 cells/mL in RPMI 1640 glutamine [-] medium (Invitrogen) supplemented with
non-essential amino acids (1%, Invitrogen), sodium pyruvate (1%, Invitrogen), glutamine (1%, Invitrogen), pooled AB human
sera (5%, UK National Blood Service), b-mercaptoethanol (0.1%, Invitrogen), penicillin/streptomycin (1%, Invitrogen) and IL-2
(500 U/mL, University of Oxford). Cells were expanded with 1 mg/mL phytohemagglutinin (Remel) in the presence of irradiated
(45 Gy) allogeneic feeder cells from 3 different healthy blood donors (106 feeder cells/mL). After 20 days, each line was screened
for the capacity to proliferate in response to HA protein. Autologous CD14+ monocytes were irradiated at 45 Gy and incubated
(33 105 cells/mL) for 5 hr at 37C with HA protein (5 mg/mL) from Influenza AWisconsin/67/2005 (a gift from Professor Stephen Har-
rison, HarvardMedical School). Negative control wells incorporated dimethyl sulfoxide (0.045%, Sigma-Aldrich), and positive control
wells incorporated IL-2 (500 U/mL, University of Oxford). An aliquot of 2.5 3 106 cells/mL from each expanded CD4+ T cell line was
added to the monocytes after washing and resting in fresh culture mediumwithout IL-2 for 5 hr. After 3 days, 1 mCi/mL [3H]-thymidine
was added to the cultures, and proliferation was measured after 16 hr using a MicroBeta2 Counter (Perkin Elmer) (Campion et al.,
2014; Geiger et al., 2009; Lindestam Arlehamn et al., 2013; Mele et al., 2017).
Antigen-specific CD4+ T cell clones
Frozen CD14-depleted PBMCs were defrosted and rested overnight at 37C in RPMI 1640 glutamine [-] medium (Invitrogen) supple-
mented with non-essential amino acids (1%, Invitrogen), sodium pyruvate (1%, Invitrogen), glutamine (1%, Invitrogen), pooled AB
human sera (10%, UK National Blood Service), b-mercaptoethanol (0.1%, Invitrogen) and penicillin/streptomycin (1%, Invitrogen).
CD4+ cells were enriched via magnetic separation using CD4 MicroBeads (Miltenyi Biotec) and surface stained as described above.
Among live lymphocytes, circulating CD3+CD4+CD45RA– cells were sorted into cTfh CXCR3+ (CXCR3+CXCR5+PD-1+), cTfh CXCR3–
(CXCR3–CXCR5+PD-1+) and cNon-Tfh (CXCR5–) subsets using a FACS Aria III (BD Biosciences). Sorted subsets (3x106 cells/mL)
were stimulated at a 3:1 ratio with irradiated (45 Gy) autologous CD14+ monocytes loaded as described above with overlapping
HA peptides (2 mg/mL) corresponding to Influenza A California/04/2009 (GenScript). Peptides were 14–18 amino acids long with a
12 residue overlap spanning the entire length of HA. After 7 days, cells were stained with Live/Dead Fixable Aqua, anti-CD3–
BV605, anti-CD4–APC-Cy7, anti-CD25–PE-Cy7, anti-CD45RA–PE-TxRed, anti-ICOS–PE and the dump marker anti-CD14 (conju-
gated to FITC) for 15 min at 37C (reagent details in Key Resources Table). Activated CD4+ T cells (CD3+CD4+CD14–CD25+ICOS+)
were sorted using a FACSAria III (BD Biosciences) and seeded at 0.4 cells/well into 384-well plates (Corning). Cells were expanded
with phytohemagglutinin (1 mg/mL, Remel) in the presence of irradiated (45 Gy) allogeneic feeder cells from 3 different healthy blood
donors (106 feeder cells/mL) in RPMI 1640 glutamine [-] medium (Invitrogen) supplemented with non-essential amino acids (1%, In-
vitrogen), sodium pyruvate (1%, Invitrogen), glutamine (1%, Invitrogen), pooled AB human sera (10%, UK National Blood Service),
b-mercaptoethanol (0.1%, Invitrogen), penicillin/streptomycin (1%, Invitrogen) and IL-2 (500 U/mL, University of Oxford). After
14 days, T cell clones were identified and transferred into 96-well round-bottom plates (Corning). To confirm specificity, an aliquot
of each clone (13 106 cells/mL) was stimulatedwith the relevant overlapping peptide pool (2 mg/mL) after washing and resting in fresh
culturemediumwithout IL-2 for 5 hr. After 3 days, 1 mCi/mL [3H]-thymidine was added to the cultures, and proliferation wasmeasured
after 16 hr using a MicroBeta2 Counter (Perkin Elmer). Positive responses were defined as >1,000 counts per min (cpm) with a
stimulation index >5 after background subtraction (cpm in wells lacking peptide). Clones were excluded from the analysis if the
background count was >1,000 cpm.
Peptide-mapping of antigen-specific CD4+ T cell clones
Antigen-specific CD4+ T cell clones were mapped using amatrix of overlapping HA peptides corresponding to Influenza A California/
04/2009, designed using ‘‘Deconvolute This!’’ (Precopio et al., 2008). Thematrix consisted of 12 pools with 18 peptides per pool and a
coverage of 3. An aliquot of each clone (1.5 3 106 cells/mL) was added to the peptide matrix (2 mg/mL) after washing and resting in
fresh culture medium without IL-2 for 5 hr. After 3 days, 1 mCi/mL [3H]-thymidine was added to the cultures, and proliferation was
measured after 16 hr using a MicroBeta2 Counter (Perkin Elmer). Positive responses were defined as >1,000 cpm with a stimulation
index >5 after background subtraction (cpm in wells lacking peptide). Peptide specificity was confirmed similarly using single
peptides identified from the matrix responses.
TCR deep-sequencing
Mononuclear cells from matched tonsil and peripheral blood samples were defrosted and rested overnight at 37C in RPMI 1640
glutamine [-] medium (Invitrogen) supplemented with non-essential amino acids (1%, Invitrogen), sodium pyruvate (1%, Invitrogen),
glutamine (1%, Invitrogen), pooled AB human sera (10%, UK National Blood Service), b-mercaptoethanol (0.1%, Invitrogen) and
penicillin/streptomycin (1%, Invitrogen). Cells were then surface stained as described above. Among live CD3+CD4+CD45RA–
lymphocytes, circulating cells were sorted into cTfh CXCR3+ (CXCR3+CXCR5+PD-1+), cTfh CXCR3– (CXCR3–CXCR5+PD-1+) andCell Reports 30, 137–152.e1–e5, January 7, 2020 e3
cNon-Tfh (CXCR5–) subsets, and cells from tonsils were sorted into tTfh GC (CXCR5hiPD-1hi), tTfh CXCR3+ (CXCR3+CXCR5intPD-
1int), tTfh CXCR3– (CXCR3–CXCR5intPD-1int) and tNon-Tfh (CXCR5–PD-1–) subsets. A maximum of 1.2x105 cells per subset was
sorted using a FACSAria III (BD Biosciences) into RLT buffer (QIAGEN) containing b-mercaptoethanol (10%, Sigma-Aldrich). Sorted
cells were stored at –80C. Each subset from donors 5, 6 and 7was sorted into two vials for technical replicates (Table S7). Total RNA
was isolated using an RNeasy Mini Kit (QIAGEN). Unique molecular identifier (UMI)-labeled 50-RACE TCRb cDNA libraries were pre-
pared using a Human TCR Profiling Kit (MiLaboratory LLC). All extracted RNA was used for cDNA synthesis, and all synthesized
cDNA was used for PCR amplification. Libraries were prepared in parallel using the same number of PCR cycles and sequenced
in parallel using a 150+150 bp NextSeq (Illumina). The total number of reads per subset is shown in Table S8.
TCR sequencing of antigen-specific CD4+ T cell clones
Antigen-specific CD4+ T cell clones were stained as described above for viability and surface expression of CD3 and CD4 (reagent
details in Key Resources Table). A maximum of 5 3 103 live CD3+CD4+ T cells was sorted into 100 mL of RNAlater (Ambion) using a
FACSAria III (BD Biosciences). Sorted cells were stored at80C. All expressed TRA and TRB gene transcripts were amplified using
an unbiased template-switch anchored RT-PCR (Quigley et al., 2011). Pure mRNA was isolated from sorted cells using mMACS
Oligo(dT) MicroBeads (Miltenyi Biotec), and cDNA was generated using a SmarterRACE Kit (Takara) with Superscript II (Invitrogen).
Transcripts were amplified using an Advantage 2 PCR Kit (Takara) with the relevant constant region primers (reagent details in Key
Resources Table). Amplicons were separated on agarose gels and extracted using a NucleoSpin Extract II Gel Extraction Kit (Ma-
cherey-Nagel). Subclones were generated using a TOPO TA Cloning Kit (Invitrogen) and One Shot Max Efficiency DH5a-T1 Compe-
tent Cells (Invitrogen). Conventional sequencing was performed as described previously (Price et al., 2005). Gene use was assigned
using the ImMunoGeneTics (IMGT) nomenclature (Lefranc, 2003).
Quantification of influenza-specific IgG
ELISA plates were coated with a commercial Trivalent Influenza Vaccine (0.75 mg/mL, Sanofi Pasteur) or HA protein from Influenza
A/California/2009 (2 mg/mL, BEI Research Resources Repository). After overnight incubation at 4C, plates were washed six times
with PBS containing 0.05% Tween-20, blocked with casein (Pierce) for 2 hr at room temperature, and washed again with PBS
containing 0.05% Tween-20. Diluted plasma samples (1:500, 1:1,000, 1:2,000 and 1:4,000) were then added in duplicate. After in-
cubation for 2 hr at room temperature, plates were washed again six times with PBS containing 0.05% Tween-20, incubated with
alkaline phosphatase-conjugated goat anti-human IgG (1 mg/mL, Sigma-Aldrich) for 1 hr at room temperature, and washed again
with PBS containing 0.05%Tween-20. Para-nitrophenylphosphate (Sigma-Aldrich) dissolved at a concentration of 1mg/mL in dieth-
anolamine buffer (Pierce) was then added for 10 min, and absorbance was read at 405 nm using a Microplate Reader (BioTek) with
Open Gen5 software (BioTek). Results were plotted as arbitrary units and standardized against a pool of four plasma samples (Miura
et al., 2008).
QUANTIFICATION AND STATISTICAL ANALYSIS
Flow cytometry data
A stop gate was set during acquisition to ensure that the same number of events was acquired and for each sample. Gates were set
on the data to determine the frequencies of the different subsets. Analogous subsets were compared between tonsil and peripheral
blood using the Wilcoxon matched pairs test. Non-analogous subsets were compared within tonsil and peripheral blood using the
Kruskal-Wallis test. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001. Boxes show means and quartiles, and whiskers show minima
and maxima.
TCR deep-sequencing analysis
A total of 933 106 TCRb sequencing reads (up to 83 106 reads per library) were obtained, fromwhich 1.553 106 unique UMI-labeled
TCRb cDNA molecules (up to 1.5 3 105 molecules per library) were assembled using MIGEC software (Shugay et al., 2014), using a
threshold of at least four sequencing reads per UMI. In-frame CDR3b repertoires were extracted usingMiXCR software (Bolotin et al.,
2015). Each library contained from 500 to 3.5 3 104 functional (in-frame, no stop-codons) CDR3b nucleotide clonotypes. Averaged
TCR repertoire characteristics weighted by clonotype size (normalized Shannon-Wiener index) were calculated using VDJtools soft-
ware (Shugay et al., 2015). As the number of cells in the populations sorted from different donors was variable as well as the total
reads, the frequency of each clonotype was normalized before analysis to allow an unbiased comparison between diverse subsets.
Network analysis was performed using Cytoscape software (https://cytoscape.org). The F2 metric for overlap between two popula-
tions was calculated as the sum of the geometric means between the frequencies of shared clonotypes, considering the top2000
clonotypes for each subset. This value was then standardized with the two maximum F2 metrics calculated for the top2000 clono-
types for each of the two populations. F2metric,% shared clonotypes and diversity indices were analyzedwith non-parametric Krus-
kal-Wallis and Dunn’s multiple comparison tests. For each test: *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001. Linear regression
correlations were calculated using the square of the Pearson correlation coefficient (R2), the slope and the p value of the significance
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Bootstrap method
The complete set of clonotypes was randomly resampledwith replacement to obtain two in silico replicates of each set of sequences.
Using this method, the replicates and the original set had similar distributions, but likely different absolute numbers, for each clono-
type. All downstream analyses were performed using the two resampled sets. Linear regression correlations between in silico rep-
licates and diversity were calculated using the p value of the difference in the slope from zero.
T cell library analysis
Positive responses were defined as >3,000 counts permin (cpm) with a stimulation index >5 after background subtraction (cpm in the
negative control wells). Because CD4+ T cells were seeded at limiting dilution, it was possible to calculate the precursor frequency of
responding cells per million according to the Poisson distribution (Campion et al., 2014; Geiger et al., 2009; Lindestam Arlehamn
et al., 2013; Mele et al., 2017). The 95%confidence intervals were determined according to themodifiedWaldmethod (Harrell, 2001).
Antigen-specific CD4+ T cell frequencies
The frequencies of expanded antigen-specific CD4+ T cell clones were calculated based on the number of clones with confirmed
specificity after expansion. Significantly diverse enrichments were identified using Kruskal-Wallis and Dunn’s multiple comparison
tests were performed. For each test: *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001.
DATA AND CODE AVAILABILITY
MIGEC, MiXCR and VDJtools software are available from MiLaboratory LLC (https://milaboratory.com/software/). The TCR
sequencing dataset supporting the current study has been deposited in the Mendeley Dataset repository (https://doi.org/10.
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